Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Inventory (2016 - 2025)

Historic Inventory for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $3.1 million.

  • STRATA Skin Sciences' Inventory rose 1144.31% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 1144.31%. This contributed to the annual value of $2.2 million for FY2024, which is 1597.46% down from last year.
  • According to the latest figures from Q3 2025, STRATA Skin Sciences' Inventory is $3.1 million, which was up 1144.31% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Inventory registered a high of $6.1 million during Q3 2023, and its lowest value of $2.2 million during Q4 2024.
  • Moreover, its 5-year median value for Inventory was $3.2 million (2021), whereas its average is $3.7 million.
  • Per our database at Business Quant, STRATA Skin Sciences' Inventory skyrocketed by 7556.59% in 2022 and then crashed by 5520.0% in 2024.
  • STRATA Skin Sciences' Inventory (Quarter) stood at $3.5 million in 2021, then fell by 11.29% to $3.1 million in 2022, then fell by 13.63% to $2.7 million in 2023, then decreased by 15.97% to $2.2 million in 2024, then surged by 36.15% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $3.2 million for Q2 2025, and $2.7 million during Q1 2025.